A detailed history of Wealth Alliance transactions in Repligen Corp stock. As of the latest transaction made, Wealth Alliance holds 1,758 shares of RGEN stock, worth $253,960. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,758
Holding current value
$253,960
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$119.79 - $167.35 $210,590 - $294,201
1,758 New
1,758 $261,000
Q1 2024

May 10, 2024

SELL
$170.78 - $208.42 $102,980 - $125,677
-603 Reduced 31.07%
1,338 $246,000
Q4 2023

Jan 30, 2024

BUY
$114.17 - $185.35 $31,625 - $51,341
277 Added 16.65%
1,941 $348,000
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $230,929 - $293,712
1,664 New
1,664 $264,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wealth Alliance Portfolio

Follow Wealth Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.